Australian Clinical Labs Limited

A$3.24As of Sun 8 Nov 2026, 12:00 UTC
ASX:ACLHealthcare
Country Australia
PE (Fwd) •••
TSR 5Y CAGR 3.63%
Div yield 4.01%
ROE 14.93%
Diagnostics & Research
Beta (5Y) 0.81
PE TTM 26.28
TSR TTM 31.15%
Mkt cap A$599.5M
ROIC 9.68%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$3.80
17.38%
(72.88%)
Hold 0|5|1|2|2
2Q26
3Q26
4Q26
1Q27
Earnings per share$
0.04
0.04
0.04
0.04
14.66%
8.12%
14.29%
13.03%
Revenue$M
27.17
28.38
28.27
27.63
8.69%
12.42%
7.28%
2.63%
Peers (US$411.8M)
Cap (US$)
PE
249.4M
—
198.0M
38.95x
404.9M
94.58x
Capital
TTM
5Y
10Y
Leveragex
0.082
(0.041)
(0.036)
EBIT/Intx
1.401
0.562
0.447
Own earn%
20.08
22.12
(14.97)
Sh yield%
18.95
39.96
38.89
Owners
Insiders/Inst%
14.31
61.72
Short interest%
5.42
SBC / revenue%
5.34
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
6
Op margin range%
11–17
$1 testx
0.0
Incr. ROIC%
26